Last reviewed · How we verify
TNF alpha inhibitors — Competitive Intelligence Brief
marketed
TNF alpha inhibitor
TNF-α (tumor necrosis factor-alpha)
Immunology
Small molecule
Live · refreshed every 30 min
Target snapshot
TNF alpha inhibitors (TNF alpha inhibitors) — Prof. Roberto Giacomelli. TNF alpha inhibitors block tumor necrosis factor-alpha, a key inflammatory cytokine that drives immune-mediated inflammation.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| TNF alpha inhibitors TARGET | TNF alpha inhibitors | Prof. Roberto Giacomelli | marketed | TNF alpha inhibitor | TNF-α (tumor necrosis factor-alpha) |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (TNF alpha inhibitor class)
- Prof. Roberto Giacomelli · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- TNF alpha inhibitors CI watch — RSS
- TNF alpha inhibitors CI watch — Atom
- TNF alpha inhibitors CI watch — JSON
- TNF alpha inhibitors alone — RSS
- Whole TNF alpha inhibitor class — RSS
Cite this brief
Drug Landscape (2026). TNF alpha inhibitors — Competitive Intelligence Brief. https://druglandscape.com/ci/tnf-alpha-inhibitors. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab